Index by author
November 01, 2010; Volume 77, Issue 11-
What’s new in treating older adults?
Barbara Messinger-Rapport, MD, PhD, CMD- Cleveland Clinic Journal of Medicine November 2010, 77 (11) 770-790;
- DOI: https://doi.org/10.3949/ccjm.77gr.10002
Recent studies and trials regarding bone loss, dialysis outcomes, dementia, and other topics.
-
Preventing clots: Don’t let the complex overshadow the simple
Brian F. Mandell, MD, PhD- Cleveland Clinic Journal of Medicine November 2010, 77 (11) 742;
- DOI: https://doi.org/10.3949/ccjm.77b.10011
Although we often approach anticoagulation therapy with a confidence born of familiarity, it is not for the faint of heart.
-
Approach to a low TSH level: Patience is a virtue
Kevin M. Pantalone, DO and Christian Nasr, MD- Cleveland Clinic Journal of Medicine November 2010, 77 (11) 803-811;
- DOI: https://doi.org/10.3949/ccjm.77a.10056
Confronted with a low TSH level, physicians should not jump to the conclusion that it is due to a hyperthyroid state.
-
How to prevent glucocorticoid-induced osteoporosis (August 2010)
Claude Bachmeyer, MD and Marion Gauthier, MD- Cleveland Clinic Journal of Medicine November 2010, 77 (11) 762;
- DOI: https://doi.org/10.3949/ccjm.77c.10002
Readers comment on preventing glucocorticoid-induced osteoporosis (August 2010) and on electronic medical records (July 2010).
-
When ‘blue babies’ grow up: What you need to know about tetralogy of Fallot
David Fox, ME, PA-C, Ganesh P. Devendra, BA, Stephen A. Hart, BS and Richard A. Krasuski, MD- Cleveland Clinic Journal of Medicine November 2010, 77 (11) 821-828;
- DOI: https://doi.org/10.3949/ccjm.77a.09172
Children born with tetralogy of Fallot and other congenital heart defects are living longer—long enough, eventually, to present to your clinic.
-
Electronic medical records (July 2010)
Emily A. Nolfo, MD- Cleveland Clinic Journal of Medicine November 2010, 77 (11) 765;
- DOI: https://doi.org/10.3949/ccjm.77c.10001
-
Intracerebral hemorrhage: Pick your poison
Franklin Michota, MD, FHM- Cleveland Clinic Journal of Medicine November 2010, 77 (11) 743-746;
- DOI: https://doi.org/10.3949/ccjm.77a.10103
Whether to resume anticoagulant therapy after an intracerebral hemorrhage requires careful consideration of many factors, including patient preferences and tolerance of different levels of risk.
-
When ‘blue babies’ grow up: What you need to know about tetralogy of Fallot
David Fox, ME, PA-C, Ganesh P. Devendra, BA, Stephen A. Hart, BS and Richard A. Krasuski, MD- Cleveland Clinic Journal of Medicine November 2010, 77 (11) 821-828;
- DOI: https://doi.org/10.3949/ccjm.77a.09172
Children born with tetralogy of Fallot and other congenital heart defects are living longer—long enough, eventually, to present to your clinic.
-
Should anticoagulation be resumed after intracerebral hemorrhage?
Joshua N. Goldstein, MD, PhD and Steven M. Greenberg, MD, PhD- Cleveland Clinic Journal of Medicine November 2010, 77 (11) 791-799;
- DOI: https://doi.org/10.3949/ccjm.77a.10018
In selected patients, the potential benefit of resuming anticoagulation outweighs the considerable risk.
-
Approach to a low TSH level: Patience is a virtue
Kevin M. Pantalone, DO and Christian Nasr, MD- Cleveland Clinic Journal of Medicine November 2010, 77 (11) 803-811;
- DOI: https://doi.org/10.3949/ccjm.77a.10056
Confronted with a low TSH level, physicians should not jump to the conclusion that it is due to a hyperthyroid state.
